CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...
NeoGenomics launched PTEN IHC CDx, the first IHC companion diagnostic test approved by the U.S. FDA for patients with ...
According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...
A new urology lab with advanced diagnostic testing is up and running at UPMC St. Margaret Hospital to deal with a slow but steady increase in the number of prostate cancer cases diagnosed each year.
Morning Overview on MSN
A targeted drug won approval for a hard-to-treat form of advanced prostate cancer
Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
Researchers have uncovered a rare inherited mutation linked to prostate cancer—and it could help identify at-risk families ...
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.
Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...
Immunotherapies, anti-cancer treatments that enhance the immune system's ability to kill cancer cells, have made notable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results